The age indications have been extended for a medicine for flatulence – Orlix® from the Valenta Pharm gastro-portfolio

The age indications have been extended for a medicine for flatulence – Orlix® from the Valenta Pharm gastro-portfolio

21.02.2019

Valenta Pharm received a new registration certificate for one of the high-potential products of its gastro-portfolio, a biologically active supplement Orlix®. From February 2019, the product is allowed for children from 3 years1.

Orlix® is based on natural alpha-galactosidase enzyme, which promptly starts the process of splitting “problematic” oligosaccharides and thereby helps prevent increased gas formation. Orlix® helps to eliminate flatulence and bloating symptoms2.

Irina Glazkova, Product Manager, Gastroenterology Business Unit, Valenta Pharm JSC: “For the proper functioning of the digestive system and a comfortable state of health, a child needs to receive 13 vitamins and more than 20 minerals and microelements daily. Unfortunately, in high life pace conditions, it can be difficult for parents to provide a full amount of nutrients for their child every day. Then Orlix®, which effectively maintains the child’s health, comes to help – now even from the age of three.”

More information about the product Orlix® on the website:http://orliks.ru/

  • 1 State registration certificate: RU.77.99.88.003. Е.005720.12.18 from 21.12.2018
  • 2 Information on the use of biologically active food supplement Orlix®